- Home
- AVTX vs PMT Comparison
AVTX vs PMT Comparison
Compare AVTX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | PMT |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 982.5M | 812.7M |
| IPO Year | 2015 | 2009 |
Fundamental Metrics
Financial Performance| Metric | AVTX | PMT |
|---|---|---|
| Price | $18.96 | $9.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $40.57 | $13.50 |
| AVG Volume (30 Days) | 718.3K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.33% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | $27,813,137.00 | ★ $351,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.55 |
| P/E Ratio | ★ N/A | $23.10 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $9.54 | $9.05 |
| 52 Week High | $24.27 | $13.80 |
Technical Indicators
Market Signals| Indicator | AVTX | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 43.99 |
| Support Level | $18.88 | $9.05 |
| Resistance Level | $20.60 | $9.83 |
| Average True Range (ATR) | 0.82 | 0.18 |
| MACD | -0.14 | 0.02 |
| Stochastic Oscillator | 33.02 | 24.58 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.